These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 20021066)
1. Platelet hyperfunction as risk factor for chronic and acute coronary events. Rao GH Toxicol Mech Methods; 2005; 15(6):425-31. PubMed ID: 20021066 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors]. Tschudi MR; Noll G; Lüscher TP Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890 [TBL] [Abstract][Full Text] [Related]
3. [Hypertension and vascular diseases: molecular and cellular mechanisms]. Lüscher TF Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405 [TBL] [Abstract][Full Text] [Related]
4. Role of platelets in the pathophysiology of acute coronary syndrome. Massberg S; Schulz C; Gawaz M Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478 [TBL] [Abstract][Full Text] [Related]
5. Factor XII (Hageman factor) is a missing link between stress and hypercoagulability and plays an important role in the pathophysiology of ischemic stroke. Eggers AE Med Hypotheses; 2006; 67(5):1065-71. PubMed ID: 16757126 [TBL] [Abstract][Full Text] [Related]
6. Non-conventional hemostatic risk factors for coronary heart disease in individuals with spinal cord injury. Khan B; Bauman WA; Sinha AK; Kahn NN Spinal Cord; 2011 Aug; 49(8):858-66. PubMed ID: 21606930 [TBL] [Abstract][Full Text] [Related]
7. Platelets: pleiotropic roles in atherogenesis and atherothrombosis. Linden MD; Jackson DE Int J Biochem Cell Biol; 2010 Nov; 42(11):1762-6. PubMed ID: 20673808 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients. Jespersen J Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796 [TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
11. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Ravindran R; Krishnan LK Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cellular synchronization in the vascular wall. Mechanisms of vasomotion. Matchkov VV Dan Med Bull; 2010 Oct; 57(10):B4191. PubMed ID: 21040688 [TBL] [Abstract][Full Text] [Related]
13. Endothelium dysfunction in the coronary circulation. Lüscher TF; Noll G J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Jennings LK Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases. Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867 [TBL] [Abstract][Full Text] [Related]
17. [The role of platelets in haemostasis, thrombosis, immune defense and inflammation]. Jurk K; Kehrel BE Dtsch Med Wochenschr; 2008 May; 133(21):1130-5. PubMed ID: 18478507 [TBL] [Abstract][Full Text] [Related]